- Conditions
- Coronary Stenosis
- Interventions
- HF-OCT Imaging, FFR Pressure Wire, Angiography
- Device
- Lead sponsor
- Gentuity, LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 150 participants
- Timeline
- 2022 – 2025
- U.S. locations
- 6
- States / cities
- Palo Alto, California • Tampa, Florida • Decatur, Georgia + 3 more
Institution Directory
Clinical trials at Beth Israel Deaconess Medical Center
Sites in Boston, MA
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
622
Shown on this page
12
Current sort
Recently updated
Campus scope
Beth Israel Deaconess Medical Center, Boston, MA
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 601–612 of 622 matching trials with a site at Beth Israel Deaconess Medical Center, Boston, MA.
Live ClinicalTrials.gov results.
Live official records
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
NCT05908331
Status at this site: Not yet recruiting
- Conditions
- In-Stent Restenosis, Cardiovascular Diseases, Coronary Artery Disease
- Interventions
- Sirolimus Drug Coated Balloon, Plan balloon Angioplasty (POBA)
- Device
- Lead sponsor
- Concept Medical Inc.
- Industry
- Eligibility
- 18 Years to 110 Years
- Enrollment
- 492 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 27
- States / cities
- Birmingham, Alabama • Gilbert, Arizona • Los Angeles, California + 21 more
Treating Schizophrenia by Correcting Abnormal Brain Development
NCT00179465
Site status not listed — check the official record
- Conditions
- Schizophrenia
- Interventions
- Tiagabine, Placebo
- Drug
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Other
- Eligibility
- 18 Years to 25 Years
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2026
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
A Diagnostic Test for Dementia With Lewy Bodies
NCT05479552
Site status not listed — check the official record
- Conditions
- MCI-AD, Early Stage Alzheimer's Disease, MCI-DLB, Early Stage Dementia With Lewy Bodies
- Interventions
- Syn-One Test
- Diagnostic Test
- Lead sponsor
- CND Life Sciences
- Other
- Eligibility
- 50 Years to 85 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 12
- States / cities
- Scottsdale, Arizona • La Jolla, California • Englewood, Colorado + 8 more
- Conditions
- Tricuspid Regurgitation
- Interventions
- TriClipTM Device
- Device
- Lead sponsor
- Abbott Medical Devices
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 572 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2029
- U.S. locations
- 63
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 51 more
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
NCT01915615
Site status not listed — check the official record
- Conditions
- Hypertrophic Cardiomyopathy
- Interventions
- None - this is an observational study
- Other
- Lead sponsor
- University of Virginia
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 2,750 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2025
- U.S. locations
- 17
- States / cities
- New Haven, Connecticut • Chicago, Illinois • Baltimore, Maryland + 10 more
BMI-based Vitamins in Obese Pregnant Women
NCT02802566
Site status not listed — check the official record
- Conditions
- Obesity
- Interventions
- BMI-based prenatal vitamin, Standard prenatal vitamin
- Dietary Supplement
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 146 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2025
- U.S. locations
- 2
- States / cities
- Boston, Massachusetts
Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)
NCT03553836
Site status not listed — check the official record
- Conditions
- Melanoma
- Interventions
- Pembrolizumab, Placebo
- Biological · Other
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 976 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2033
- U.S. locations
- 39
- States / cities
- Tucson, Arizona • La Jolla, California • Los Angeles, California + 28 more
- Conditions
- Preterm Labor, Preterm Birth, Preterm Birth Complication, Preterm Premature Rupture of Membrane, Preeclampsia, HELLP, Gestational Hypertension, Gestational Diabetes Mellitus in Pregnancy, Small for Gestational Age at Delivery, Intrauterine Growth Restriction
- Interventions
- Mirvie Predictive Test for Adverse Pregnancy Outcomes
- Diagnostic Test
- Lead sponsor
- Mirvie
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 10,000 participants
- Timeline
- 2021 – 2025
- U.S. locations
- 10
- States / cities
- San Diego, California • Orlando, Florida • New Orleans, Louisiana + 7 more
Memory Retrieval and Encoding Investigated by Neural Stimulation
NCT04286776
Site status not listed — check the official record
- Conditions
- Epilepsy Intractable
- Interventions
- Direct electrical stimulation
- Device
- Lead sponsor
- University of Pennsylvania
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 800 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2024
- U.S. locations
- 11
- States / cities
- Aurora, Colorado • Atlanta, Georgia • Bethesda, Maryland + 7 more
Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma
NCT03422003
Site status not listed — check the official record
- Conditions
- Breast Cancer
- Interventions
- Radiation Therapy
- Radiation
- Lead sponsor
- Dana-Farber Cancer Institute
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2030
- U.S. locations
- 15
- States / cities
- San Francisco, California • Stanford, California • Edwards, Colorado + 10 more
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
NCT04598750
Status at this site: Not yet recruiting
- Conditions
- Neonatal Thrombocytopenia, Bleeding
- Interventions
- Not listed
- Lead sponsor
- Karolinska Institutet
- Other
- Eligibility
- 1 Day and older
- Enrollment
- 250 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2025
- U.S. locations
- 4
- States / cities
- Boston, Massachusetts • Murray, Utah • Provo, Utah
About this Beth Israel Deaconess Medical Center institution page
- What this page lists
- ClinicalTrials.gov records that list Beth Israel Deaconess Medical Center in Boston, MA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
- Site status
- A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
- Where the data comes from
- Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
- What this page does not do
- No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages, browse by condition, or browse by U.S. city.